There are not any FDA-approved therapies for GPC3, a protein extremely expressed by liver cancers. Oricell Therapeutics claims its cell remedy might be greatest on this class, however it faces competitors from corporations reminiscent of AstraZeneca and Eureka Therapeutics.
The put up Oricell Lands $110M to Take Cell Remedy to New Territory in Most cancers appeared first on MedCity Information.
